| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
1.29 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
1.29 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
1.29 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
1.29 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
1.29 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
1.29 |
Evidence |
|
| P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
1.29 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
EPOR |
EPOR: Erythropoietin receptor precursor |
1.29 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
1.29 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.29 |
Evidence |
|
| F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
1.29 |
Evidence |
|
| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
1.29 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
1.29 |
Evidence |
O
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
1.29 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
1.29 |
Evidence |
|
| TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.29 |
Evidence |
O
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
1.29 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
1.29 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
1.29 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
1.29 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
1.29 |
Evidence |
|
| CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
1.29 |
Evidence |
|
| PCDH7 |
PCDH7, BHPCDH: Protocadherin-7 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
1.29 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
1.29 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.29 |
Evidence |
|